)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
The pharmaceutical company reported robust growth in domestic formulations and insulin franchise performance, while maintaining a strong EBITDA margin of 37 per cent
Credit rating agency says domestic two-wheeler wholesale volumes may grow 3-5% in FY27, while exports and electric vehicle demand continue to support the industry
HAB Pharmaceuticals aims to scale operations and expand globally after merging with Signature Phytochemical Industries through a slump sale deal
NephroPlus posted a 74.6% jump in FY26 profit as higher dialysis volumes and rapid international expansion boosted revenue and margins
Dr Reddy's CEO Erez Israeli says semaglutide, biosimilars and oncology will drive the company's next growth phase as it expands beyond traditional generics globally
Hospitals, diagnostics firms, and support groups are expanding cancer care into tier-2 and tier-3 cities as demand, screening and awareness rise beyond large metros
Harsh Goenka says the conglomerate is expanding remote work, limiting travel and accelerating electric mobility adoption amid West Asia tensions
KPMG report says government schemes, rising urban mobility demand and improving economics are accelerating growth in India's electric bus market
Drugmaker cites lower contribution from key US products, higher R&D investments and rising operating costs as Q4 FY26 profit declines sharply
GIC and TPG-backed Asia Healthcare Holdings has inducted three independent directors as it expands its specialty healthcare network across India
India's EV industry sees stronger momentum after Prime Minister Narendra Modi renewed his push for electric mobility amid rising sales and infrastructure growth
Bajaj Auto, Hero MotoCorp and Ather Energy flag rising commodity prices, freight costs and supply-chain disruptions as geopolitical tensions weigh on demand and margins
Biocon is scouting for biosimilar in-licensing opportunities while banking on multiple FY27 product launches to drive growth, margins, and market expansion
Bharat Forge reported a 17.5 per cent decline in Q4 net profit due to labour code-related charges and expects around 25 per cent revenue growth in FY27
Mahindra Group has appointed Vimal Agarwal as Group Chief Internal Auditor from July 1, 2026, as the conglomerate sharpens its focus on governance and internal controls
India's electric vehicle market recorded strong annual growth in April 2026, led by a sharp rise in passenger vehicle sales and broader consumer adoption
The rise in profits was attributed to the robust performance in international markets and growth in new launches from Emcure's in-house portfolio
Strained Centre-state relations had long made investors wary, a sentiment reinforced by Trinamool leader Mamata Banerjee's rise on the back of a land agitation in Singur and Nandigram
The company posted a net loss of ₹100.2 crore in Q4 FY26, compared with a loss of ₹234.3 crore in the year-ago period
Aggressive discounting persists in the EV market as automakers juggle inventory, competition, and evolving buyer expectations